Cardinal Health's Strategic Moves Propel Stock to New Heights

Cardinal Health’s Strategic Moves Propel Stock to New Heights

Cardinal Health (NYSE: CAH) has recently achieved significant milestones, including strategic acquisitions and robust financial performance, leading to a notable increase in its stock price.

Acquisition of Solaris Health

In November 2025, Cardinal Health completed the acquisition of Solaris Health, the nation’s leading urology management services organization (MSO). This acquisition added over 750 providers across more than 250 practice locations in 14 states to Cardinal Health’s multi-specialty MSO platform, The Specialty Alliance. This expansion enhances Cardinal Health’s presence in the urology sector and strengthens its position in the integrated healthcare services market.

Strong Financial Performance

Cardinal Health’s financial results for the second quarter of fiscal year 2026, reported in February 2026, showcased impressive growth. The company reported a 19% increase in revenue, reaching $65.6 billion. GAAP operating earnings rose by 29% to $707 million, while non-GAAP operating earnings increased by 38% to $877 million. These strong results led the company to raise its fiscal year 2026 non-GAAP EPS guidance to a range of $10.15 to $10.35.

Stock Performance

As of July 10, 2026, Cardinal Health’s stock price reached $235.80, reflecting a 1.17% increase from the previous close. This upward trend underscores investor confidence in the company’s strategic direction and financial health.

Analyst Outlook

Analysts have responded positively to Cardinal Health’s recent performance. William Blair initiated coverage with an “Outperform” rating, citing the company’s durable competitive moat in pharmaceutical distribution. Additionally, CNBC’s Jim Cramer highlighted Cardinal Health as a strong investment alternative to high-flying technology stocks, emphasizing its solid position in the healthcare sector.

Conclusion

Cardinal Health’s strategic acquisition of Solaris Health and its robust financial performance have significantly contributed to its stock’s upward trajectory. These developments reflect the company’s commitment to expanding its integrated healthcare services and products, positioning it favorably in the market.